{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:36:01Z","timestamp":1774352161507,"version":"3.50.1"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00296-020-04764-5","type":"journal-article","created":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T12:02:46Z","timestamp":1609675366000},"page":"243-256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-311X","authenticated-orcid":false,"given":"Sakir","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8749-6018","authenticated-orcid":false,"given":"Armen Yuri","family":"Gasparyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"key":"4764_CR1","first-page":"S131","volume":"32","author":"A Molt\u00f3","year":"2014","unstructured":"Molt\u00f3 A, Dougados M (2014) Comorbidity indices. Clin Exp Rheumatol 32:S131-134","journal-title":"Clin Exp Rheumatol"},{"key":"4764_CR2","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1136\/annrheumdis-2016-209233","volume":"75","author":"A Baillet","year":"2016","unstructured":"Baillet A, Gossec L, Carmona L et al (2016) Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann Rheum Dis 75:965\u2013973. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209233","journal-title":"Ann Rheum Dis"},{"key":"4764_CR3","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/annrheumdis-2016-210275","volume":"76","author":"O Schieir","year":"2017","unstructured":"Schieir O, Tosevski C, Glazier RH et al (2017) Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis. Ann Rheum Dis 76:1396\u20131404. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210275","journal-title":"Ann Rheum Dis"},{"key":"4764_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nrrheum.2011.2","volume":"7","author":"RR Edwards","year":"2011","unstructured":"Edwards RR, Cahalan C, Calahan C et al (2011) Pain, catastrophizing, and depression in the rheumatic diseases. Nat Rev Rheumatol 7:216\u2013224. https:\/\/doi.org\/10.1038\/nrrheum.2011.2","journal-title":"Nat Rev Rheumatol"},{"key":"4764_CR5","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrrheum.2017.172","volume":"13","author":"RH Straub","year":"2017","unstructured":"Straub RH (2017) The brain and immune system prompt energy shortage in chronic inflammation and ageing. Nat Rev Rheumatol 13:743\u2013751. https:\/\/doi.org\/10.1038\/nrrheum.2017.172","journal-title":"Nat Rev Rheumatol"},{"key":"4764_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","volume":"17","author":"TA Simon","year":"2015","unstructured":"Simon TA, Thompson A, Gandhi KK et al (2015) Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther 17:212. https:\/\/doi.org\/10.1186\/s13075-015-0728-9","journal-title":"Arthritis Res Ther"},{"key":"4764_CR7","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1007\/s10067-020-05301-2","volume":"39","author":"CS Santos","year":"2020","unstructured":"Santos CS, Morales CM, \u00c1lvarez ED et al (2020) Determinants of COVID-19 disease severity in patients with underlying rheumatic disease. Clin Rheumatol 39:2789\u20132796. https:\/\/doi.org\/10.1007\/s10067-020-05301-2","journal-title":"Clin Rheumatol"},{"key":"4764_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41584-020-0463-8","volume":"16","author":"S Onuora","year":"2020","unstructured":"Onuora S (2020) New data emerging on outcomes for patients with COVID-19 and rheumatic diseases. Nat Rev Rheumatol 16:407. https:\/\/doi.org\/10.1038\/s41584-020-0463-8","journal-title":"Nat Rev Rheumatol"},{"key":"4764_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","volume":"79","author":"M Gianfrancesco","year":"2020","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S et al (2020) Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 79:859\u2013866. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217871","journal-title":"Ann Rheum Dis"},{"key":"4764_CR10","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"4764_CR11","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/annrheumdis-2020-217627","volume":"79","author":"C Ye","year":"2020","unstructured":"Ye C, Cai S, Shen G et al (2020) Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China. Ann Rheum Dis 79:1007\u20131013. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217627","journal-title":"Ann Rheum Dis"},{"key":"4764_CR12","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1136\/annrheumdis-2020-217763","volume":"79","author":"JL Pablos","year":"2020","unstructured":"Pablos JL, Abasolo L, Alvaro-Gracia JM et al (2020) Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases. Ann Rheum Dis 79:1170\u20131173. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217763","journal-title":"Ann Rheum Dis"},{"key":"4764_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05494-6","author":"S Kipps","year":"2020","unstructured":"Kipps S, Paul A, Vasireddy S (2020) Incidence of COVID-19 in patients with rheumatic disease: is prior health education more important than shielding advice during the pandemic? Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-020-05494-6","journal-title":"Clin Rheumatol"},{"key":"4764_CR14","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/annrheumdis-2020-217888","volume":"79","author":"KM D\u2019Silva","year":"2020","unstructured":"D\u2019Silva KM, Serling-Boyd N, Wallwork R et al (2020) Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US \u2018hot spot.\u2019 Ann Rheum Dis 79:1156\u20131162. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217888","journal-title":"Ann Rheum Dis"},{"key":"4764_CR15","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/annrheumdis-2020-217948","volume":"79","author":"C Sanchez-Piedra","year":"2020","unstructured":"Sanchez-Piedra C, Diaz-Torne C, Manero J et al (2020) Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies. Ann Rheum Dis 79:988\u2013990. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217948","journal-title":"Ann Rheum Dis"},{"key":"4764_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217984","author":"DD Freites Nu\u00f1ez","year":"2020","unstructured":"Freites Nu\u00f1ez DD, Leon L, Mucientes A et al (2020) Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217984","journal-title":"Ann Rheum Dis"},{"key":"4764_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218296","author":"JL Pablos","year":"2020","unstructured":"Pablos JL, Galindo M, Carmona L et al (2020) Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218296","journal-title":"Ann Rheum Dis"},{"key":"4764_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218054","author":"L Nu\u00f1o","year":"2020","unstructured":"Nu\u00f1o L, Navarro MN, Bonilla G et al (2020) Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218054","journal-title":"Ann Rheum Dis"},{"key":"4764_CR19","first-page":"748","volume":"38","author":"CA Scir\u00e8","year":"2020","unstructured":"Scir\u00e8 CA, Carrara G, Zanetti A et al (2020) COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19). Clin Exp Rheumatol 38:748\u2013753","journal-title":"Clin Exp Rheumatol"},{"key":"4764_CR20","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s10067-020-05160-x","volume":"39","author":"C Cheng","year":"2020","unstructured":"Cheng C, Li C, Zhao T et al (2020) COVID-19 with rheumatic diseases: a report of 5 cases. Clin Rheumatol 39:2025\u20132029. https:\/\/doi.org\/10.1007\/s10067-020-05160-x","journal-title":"Clin Rheumatol"},{"key":"4764_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jbspin.2020.05.003","volume":"87","author":"L Quartuccio","year":"2020","unstructured":"Quartuccio L, Valent F, Pasut E et al (2020) Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy. Joint Bone Spine 87:439\u2013443. https:\/\/doi.org\/10.1016\/j.jbspin.2020.05.003","journal-title":"Joint Bone Spine"},{"key":"4764_CR22","doi-asserted-by":"publisher","first-page":"e001332","DOI":"10.1136\/rmdopen-2020-001332","volume":"6","author":"R Hasseli","year":"2020","unstructured":"Hasseli R, Mueller-Ladner U, Schmeiser T et al (2020) National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD. RMD Open 6:e001332. https:\/\/doi.org\/10.1136\/rmdopen-2020-001332","journal-title":"RMD Open"},{"key":"4764_CR23","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00296-020-04635-z","volume":"40","author":"I Coskun Benlidayi","year":"2020","unstructured":"Coskun Benlidayi I, Kurtaran B, Tirasci E, Guzel R (2020) Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review. Rheumatol Int 40:1707\u20131716. https:\/\/doi.org\/10.1007\/s00296-020-04635-z","journal-title":"Rheumatol Int"},{"key":"4764_CR24","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00296-020-04676-4","volume":"40","author":"F Montero","year":"2020","unstructured":"Montero F, Mart\u00ednez-Barrio J, Serrano-Benavente B et al (2020) Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes. Rheumatol Int 40:1593\u20131598. https:\/\/doi.org\/10.1007\/s00296-020-04676-4","journal-title":"Rheumatol Int"},{"key":"4764_CR25","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s00296-020-04699-x","volume":"40","author":"J Loarce-Martos","year":"2020","unstructured":"Loarce-Martos J, Garc\u00eda-Fern\u00e1ndez A, L\u00f3pez-Guti\u00e9rrez F et al (2020) High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study. Rheumatol Int 40:2015\u20132021. https:\/\/doi.org\/10.1007\/s00296-020-04699-x","journal-title":"Rheumatol Int"},{"key":"4764_CR26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.semarthrit.2020.07.012","volume":"50","author":"H So","year":"2020","unstructured":"So H, MAK JW-Y, SO J et al (2020) Incidence and clinical course of COVID-19 in patients with rheumatologic diseases: a population-based study. Semin Arthritis Rheum 50:885\u2013889. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.07.012","journal-title":"Semin Arthritis Rheum"},{"key":"4764_CR27","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.semarthrit.2020.05.010","volume":"50","author":"S Sharmeen","year":"2020","unstructured":"Sharmeen S, Elghawy A, Zarlasht F, Yao Q (2020) COVID-19 in rheumatic disease patients on immunosuppressive agents. Semin Arthritis Rheum 50:680\u2013686. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.05.010","journal-title":"Semin Arthritis Rheum"},{"key":"4764_CR28","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.semarthrit.2020.05.001","volume":"50","author":"X Michelena","year":"2020","unstructured":"Michelena X, Borrell H, L\u00f3pez-Corbeto M et al (2020) Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs. Semin Arthritis Rheum 50:564\u2013570. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.05.001","journal-title":"Semin Arthritis Rheum"},{"key":"4764_CR29","doi-asserted-by":"publisher","first-page":"e549","DOI":"10.1016\/S2665-9913(20)30169-7","volume":"2","author":"M Fredi","year":"2020","unstructured":"Fredi M, Cavazzana I, Moschetti L et al (2020) COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case\u2013control study. Lancet Rheumatol 2:e549\u2013e556. https:\/\/doi.org\/10.1016\/S2665-9913(20)30169-7","journal-title":"Lancet Rheumatol"},{"key":"4764_CR30","doi-asserted-by":"publisher","first-page":"e557","DOI":"10.1016\/S2665-9913(20)30227-7","volume":"2","author":"J Zhong","year":"2020","unstructured":"Zhong J, Shen G, Yang H et al (2020) COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study. Lancet Rheumatol 2:e557\u2013e564. https:\/\/doi.org\/10.1016\/S2665-9913(20)30227-7","journal-title":"Lancet Rheumatol"},{"key":"4764_CR31","doi-asserted-by":"publisher","first-page":"rkaa055","DOI":"10.1093\/rap\/rkaa055","volume":"4","author":"A Pistone","year":"2020","unstructured":"Pistone A, Tant L, Soyfoo MS (2020) Clinical course of COVID-19 infection in inflammatory rheumatological patients: a monocentric Belgian experience. Rheumatol Adv Pract 4:rkaa055. https:\/\/doi.org\/10.1093\/rap\/rkaa055","journal-title":"Rheumatol Adv Pract"},{"key":"4764_CR32","doi-asserted-by":"publisher","first-page":"8860492","DOI":"10.1155\/2020\/8860492","volume":"2020","author":"WJS Tiendr\u00e9b\u00e9ogo","year":"2019","unstructured":"Tiendr\u00e9b\u00e9ogo WJS, Kabor\u00e9 F, Diend\u00e9r\u00e9 EA, Ouedraogo DD (2020) Case series of chronic inflammatory rheumatic disease patients infected by coronavirus disease 2019 (COVID-19). Case Rep Rheumatol 2020:8860492. https:\/\/doi.org\/10.1155\/2020\/8860492","journal-title":"Case Rep Rheumatol"},{"key":"4764_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkaa061","author":"M Lwin","year":"2020","unstructured":"Lwin M, Holroyd C, Wallis D et al (2020) Does COVID-19 cause an increased risk of hospitalisation or death in patients with inflammatory rheumatic diseases treated with bDMARDs or tsDMARDs? Rheumatol Adv Pract. https:\/\/doi.org\/10.1093\/rap\/rkaa061","journal-title":"Rheumatol Adv Pract"},{"key":"4764_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa694","author":"K Murray","year":"2020","unstructured":"Murray K, Quinn S, Turk M et al (2020) COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population. Rheumatology (Oxford) keaa694. https:\/\/doi.org\/10.1093\/rheumatology\/keaa694","journal-title":"Rheumatology (Oxford) keaa694"},{"key":"4764_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2020.105095","author":"F Costantino","year":"2020","unstructured":"Costantino F, Bahier L, Taranc\u00f3n LC et al (2020) COVID-19 in French patients with chronic inflammatory rheumatic diseases: clinical features, risk factors and treatment adherence. Joint Bone Spine. https:\/\/doi.org\/10.1016\/j.jbspin.2020.105095","journal-title":"Joint Bone Spine"},{"key":"4764_CR36","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","journal-title":"The Lancet"},{"key":"4764_CR37","doi-asserted-by":"publisher","first-page":"154262","DOI":"10.1016\/j.metabol.2020.154262","volume":"108","author":"L Palaiodimos","year":"2020","unstructured":"Palaiodimos L, Kokkinidis DG, Li W et al. (2020) Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx New York. Metabolism 108:154262. DOI: 10.1016\/j.metabol.2020.154262","journal-title":"Metabolism"},{"key":"4764_CR38","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMsa2011686","volume":"382","author":"EG Price-Haywood","year":"2020","unstructured":"Price-Haywood EG, Burton J, Fort D, Seooane L (2020) Hospitalization and mortality among black patients and white patients with COVID-19. N Engl J Med 382:2534\u20132543. https:\/\/doi.org\/10.1056\/NEJMsa2011686","journal-title":"N Engl J Med"},{"key":"4764_CR39","doi-asserted-by":"publisher","first-page":"e0238215","DOI":"10.1371\/journal.pone.0238215","volume":"15","author":"P Ssentongo","year":"2020","unstructured":"Ssentongo P, Ssentongo AE, Heilbrunn ES et al (2020) Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: a systematic review and meta-analysis. PLoS ONE 15:e0238215. https:\/\/doi.org\/10.1371\/journal.pone.0238215","journal-title":"PLoS ONE"},{"key":"4764_CR40","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","volume":"81","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Peng F, Xu B et al (2020) Risk factors of critical and mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect 81:e16\u2013e25. https:\/\/doi.org\/10.1016\/j.jinf.2020.04.021","journal-title":"J Infect"},{"key":"4764_CR41","doi-asserted-by":"publisher","first-page":"104949","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104949","volume":"29","author":"R Pranata","year":"2020","unstructured":"Pranata R, Huang I, Lim MA et al (2020) Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 29:104949. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104949","journal-title":"J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc"},{"key":"4764_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","volume":"94","author":"J Yang","year":"2020","unstructured":"Yang J, Zheng Y, Gou X et al (2020) Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 94:91\u201395. https:\/\/doi.org\/10.1016\/j.ijid.2020.03.017","journal-title":"Int J Infect Dis"},{"key":"4764_CR43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","volume":"109","author":"B Li","year":"2020","unstructured":"Li B, Yang J, Zhao F et al (2020) Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 109:531\u2013538. https:\/\/doi.org\/10.1007\/s00392-020-01626-9","journal-title":"Clin Res Cardiol"},{"key":"4764_CR44","doi-asserted-by":"publisher","first-page":"e0233147","DOI":"10.1371\/journal.pone.0233147","volume":"15","author":"JS Alqahtani","year":"2020","unstructured":"Alqahtani JS, Oyelade T, Aldhahir AM et al (2020) Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS ONE 15:e0233147. https:\/\/doi.org\/10.1371\/journal.pone.0233147","journal-title":"PLoS ONE"},{"key":"4764_CR45","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.dsx.2020.04.018","volume":"14","author":"I Huang","year":"2020","unstructured":"Huang I, Lim MA, Pranata R (2020) Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 14:395\u2013403. https:\/\/doi.org\/10.1016\/j.dsx.2020.04.018","journal-title":"Diabetes Metab Syndr"},{"key":"4764_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-020-01546-0","author":"Z Wu","year":"2020","unstructured":"Wu Z, Tang Y, Cheng Q (2020) Diabetes increases the mortality of patients with COVID-19: a meta-analysis. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-020-01546-0","journal-title":"Acta Diabetol"},{"key":"4764_CR47","doi-asserted-by":"publisher","first-page":"104354","DOI":"10.1016\/j.jcv.2020.104354","volume":"127","author":"L Roncon","year":"2020","unstructured":"Roncon L, Zuin M, Rigatelli G, Zuliani G (2020) Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol Off Publ Pan Am Soc Clin Virol 127:104354. https:\/\/doi.org\/10.1016\/j.jcv.2020.104354","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"key":"4764_CR48","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s40618-020-01236-2","volume":"43","author":"GP Fadini","year":"2020","unstructured":"Fadini GP, Morieri ML, Longato E, Avogaro A (2020) Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest 43:867\u2013869. https:\/\/doi.org\/10.1007\/s40618-020-01236-2","journal-title":"J Endocrinol Invest"},{"key":"4764_CR49","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/jendso\/bvaa102","volume":"4","author":"FJ Barrera","year":"2020","unstructured":"Barrera FJ, Shekhar S, Wurth R et al (2020) Prevalence of diabetes and hypertension and their associated risks for poor outcomes in COVID-19 patients. J Endocr Soc 4:102. https:\/\/doi.org\/10.1210\/jendso\/bvaa102","journal-title":"J Endocr Soc"},{"key":"4764_CR50","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.dsx.2020.04.044","volume":"14","author":"A Kumar","year":"2020","unstructured":"Kumar A, Arora A, Sharma P et al (2020) Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr 14:535\u2013545. https:\/\/doi.org\/10.1016\/j.dsx.2020.04.044","journal-title":"Diabetes Metab Syndr"},{"key":"4764_CR51","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.jinf.2020.06.060","volume":"81","author":"X Liang","year":"2020","unstructured":"Liang X, Shi L, Wang Y et al (2020) The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates. J Infect 81:e44\u2013e47. https:\/\/doi.org\/10.1016\/j.jinf.2020.06.060","journal-title":"J Infect"},{"key":"4764_CR52","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1017\/S095026882000117X","volume":"148","author":"J Zhang","year":"2020","unstructured":"Zhang J, Wu J, Sun X et al (2020) Association of hypertension with the severity and fatality of SARS-CoV-2 infection: a meta-analysis. Epidemiol Infect 148:e106. https:\/\/doi.org\/10.1017\/S095026882000117X","journal-title":"Epidemiol Infect"},{"key":"4764_CR53","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1016\/j.jinf.2020.03.059","volume":"81","author":"M Zuin","year":"2020","unstructured":"Zuin M, Rigatelli G, Zuliani G et al (2020) Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis. J Infect 81:e84\u2013e86. https:\/\/doi.org\/10.1016\/j.jinf.2020.03.059","journal-title":"J Infect"},{"key":"4764_CR54","doi-asserted-by":"publisher","unstructured":"Pranata R, Lim MA, Huang I et al (2020) Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression. J Renin-Angiotensin-Aldosterone Syst JRAAS 21:1470320320926899 doi: https:\/\/doi.org\/10.1177\/1470320320926899","DOI":"10.1177\/1470320320926899"},{"key":"4764_CR55","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.orcp.2020.07.002","volume":"14","author":"A Hussain","year":"2020","unstructured":"Hussain A, Mahawar K, Xia Z et al (2020) Obesity and mortality of COVID-19. Meta-analysis Obes Res Clin Pract 14:295\u2013300. https:\/\/doi.org\/10.1016\/j.orcp.2020.07.002","journal-title":"Meta-analysis Obes Res Clin Pract"},{"key":"4764_CR56","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.jinf.2020.05.065","volume":"81","author":"M Liu","year":"2020","unstructured":"Liu M, Gao Y, Zhang Y et al (2020) The association between severe or dead COVID-19 and autoimmune diseases: a systematic review and meta-analysis. J Infect 81:e93\u2013e95. https:\/\/doi.org\/10.1016\/j.jinf.2020.05.065","journal-title":"J Infect"},{"key":"4764_CR57","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1007\/s10067-019-04579-1","volume":"38","author":"B Batko","year":"2019","unstructured":"Batko B, Urba\u0144ski K, \u015awierkot J et al (2019) Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis. Clin Rheumatol 38:2473\u20132481. https:\/\/doi.org\/10.1007\/s10067-019-04579-1","journal-title":"Clin Rheumatol"},{"key":"4764_CR58","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00296-020-04612-6","volume":"40","author":"ED Batu","year":"2020","unstructured":"Batu ED, \u00d6zen S (2020) Implications of COVID-19 in pediatric rheumatology. Rheumatol Int 40:1193\u20131213. https:\/\/doi.org\/10.1007\/s00296-020-04612-6","journal-title":"Rheumatol Int"},{"key":"4764_CR59","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrrheum.2014.121","volume":"10","author":"G Kerekes","year":"2014","unstructured":"Kerekes G, Nurmohamed MT, Gonz\u00e1lez-Gay MA et al (2014) Rheumatoid arthritis and metabolic syndrome. Nat Rev Rheumatol 10:691\u2013696. https:\/\/doi.org\/10.1038\/nrrheum.2014.121","journal-title":"Nat Rev Rheumatol"},{"key":"4764_CR60","doi-asserted-by":"publisher","first-page":"e0170361","DOI":"10.1371\/journal.pone.0170361","volume":"12","author":"J Hallajzadeh","year":"2017","unstructured":"Hallajzadeh J, Safiri S, Mansournia MA et al (2017) Metabolic syndrome and its components among rheumatoid arthritis patients: a comprehensive updated systematic review and meta-analysis. PLoS ONE 12:e0170361. https:\/\/doi.org\/10.1371\/journal.pone.0170361","journal-title":"PLoS ONE"},{"key":"4764_CR61","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00296-018-4084-3","volume":"38","author":"LL Castro","year":"2018","unstructured":"Castro LL, Lanna CCD, Rocha MP et al (2018) Recognition and control of hypertension, diabetes, and dyslipidemia in patients with rheumatoid arthritis. Rheumatol Int 38:1437\u20131442. https:\/\/doi.org\/10.1007\/s00296-018-4084-3","journal-title":"Rheumatol Int"},{"key":"4764_CR62","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s42358-019-0089-1","volume":"59","author":"MFB de Resende Guimar\u00e3es","year":"2019","unstructured":"de Resende Guimar\u00e3es MFB, Rodrigues CEM, Gomes KWP et al (2019) High prevalence of obesity in rheumatoid arthritis patients: association with disease activity, hypertension, dyslipidemia and diabetes, a multi-center study. Adv Rheumatol 59:44. https:\/\/doi.org\/10.1186\/s42358-019-0089-1","journal-title":"Adv Rheumatol Lond Engl"},{"key":"4764_CR63","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/rheumatology\/kew039","volume":"55","author":"DF van Breukelen-van der Stoep","year":"2016","unstructured":"van Breukelen-van der Stoep DF, van Zeben D, Klop B et al (2016) Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis. Rheumatology (Oxford) 55:1210\u20131216. https:\/\/doi.org\/10.1093\/rheumatology\/kew039","journal-title":"Rheumatology (Oxford)"},{"key":"4764_CR64","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1007\/s10067-018-4113-3","volume":"37","author":"DA Pappas","year":"2018","unstructured":"Pappas DA, Nyberg F, Kremer JM et al (2018) Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study. Clin Rheumatol 37:2331\u20132340. https:\/\/doi.org\/10.1007\/s10067-018-4113-3","journal-title":"Clin Rheumatol"},{"key":"4764_CR65","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/rheumatology\/kex414","volume":"57","author":"K Albrecht","year":"2018","unstructured":"Albrecht K, Luque Ramos A, Hoffmann F et al (2018) High prevalence of diabetes in patients with rheumatoid arthritis: results from a questionnaire survey linked to claims data. Rheumatology (Oxford) 57:329\u2013336. https:\/\/doi.org\/10.1093\/rheumatology\/kex414","journal-title":"Rheumatology (Oxford)"},{"key":"4764_CR66","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/rheumatology\/kes262","volume":"52","author":"S Norton","year":"2013","unstructured":"Norton S, Koduri G, Nikiphorou E et al (2013) A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology (Oxford) 52:99\u2013110. https:\/\/doi.org\/10.1093\/rheumatology\/kes262","journal-title":"Rheumatology (Oxford)"},{"key":"4764_CR67","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/art.40574","volume":"70","author":"P Spagnolo","year":"2018","unstructured":"Spagnolo P, Lee JS, Sverzellati N et al (2018) The lung in rheumatoid arthritis: focus on interstitial lung disease. Arthritis Rheumatol 70:1544\u20131554. https:\/\/doi.org\/10.1002\/art.40574","journal-title":"Arthritis Rheumatol"},{"key":"4764_CR68","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/annrheumdis-2017-211735","volume":"77","author":"CS Crowson","year":"2018","unstructured":"Crowson CS, Rollefstad S, Ikdahl E et al (2018) Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis. Ann Rheum Dis 77:48\u201354. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211735","journal-title":"Ann Rheum Dis"},{"key":"4764_CR69","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1007\/s10067-019-04646-7","volume":"38","author":"A Ortolan","year":"2019","unstructured":"Ortolan A, Lorenzin M, Tadiotto G et al (2019) Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients. Clin Rheumatol 38:2843\u20132850. https:\/\/doi.org\/10.1007\/s10067-019-04646-7","journal-title":"Clin Rheumatol"},{"key":"4764_CR70","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5152\/eurjrheum.2017.16052","volume":"4","author":"SG \u00d6zkan","year":"2017","unstructured":"\u00d6zkan SG, Yaz\u0131s\u0131z H, Behl\u00fcl A et al (2017) Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with psoriatic arthritis. Eur J Rheumatol 4:40\u201345. https:\/\/doi.org\/10.5152\/eurjrheum.2017.16052","journal-title":"Eur J Rheumatol"},{"key":"4764_CR71","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10067-017-3975-0","volume":"37","author":"F Caso","year":"2018","unstructured":"Caso F, Del Puente A, Oliviero F et al (2018) Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study. Clin Rheumatol 37:579\u2013586. https:\/\/doi.org\/10.1007\/s10067-017-3975-0","journal-title":"Clin Rheumatol"},{"key":"4764_CR72","first-page":"182","volume":"32","author":"MH Favarato","year":"2014","unstructured":"Favarato MH, Mease P, Gon\u00e7alves CR et al (2014) Hypertension and diabetes significantly enhance the risk of cardiovascular disease in patients with psoriatic arthritis. Clin Exp Rheumatol 32:182\u2013187","journal-title":"Clin Exp Rheumatol"},{"key":"4764_CR73","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s10067-019-04519-z","volume":"38","author":"R Queiro","year":"2019","unstructured":"Queiro R, Lorenzo A, Tej\u00f3n P et al (2019) Hypertension is associated with increased age at the onset of psoriasis and a higher body mass index in psoriatic disease. Clin Rheumatol 38:2063\u20132068. https:\/\/doi.org\/10.1007\/s10067-019-04519-z","journal-title":"Clin Rheumatol"},{"key":"4764_CR74","doi-asserted-by":"publisher","first-page":"e16400","DOI":"10.1097\/MD.0000000000016400","volume":"98","author":"R Queiro","year":"2019","unstructured":"Queiro R, Lorenzo A, Tej\u00f3n P et al (2019) Obesity in psoriatic arthritis: comparative prevalence and associated factors. Medicine (Baltimore) 98:e16400. https:\/\/doi.org\/10.1097\/MD.0000000000016400","journal-title":"Medicine (Baltimore)"},{"key":"4764_CR75","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/acr.23171","volume":"69","author":"H Radner","year":"2017","unstructured":"Radner H, Lesperance T, Accortt NA, Solomon DH (2017) Incidence and prevalence of cardiovascular risk factors among patients with rheumatoid arthritis, psoriasis, or psoriatic arthritis. Arthritis Care Res 69:1510\u20131518. https:\/\/doi.org\/10.1002\/acr.23171","journal-title":"Arthritis Care Res"},{"key":"4764_CR76","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/rheumatology\/ket343","volume":"53","author":"M Dubreuil","year":"2014","unstructured":"Dubreuil M, Rho YH, Man A et al (2014) Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study. Rheumatology (Oxford) 53:346\u2013352. https:\/\/doi.org\/10.1093\/rheumatology\/ket343","journal-title":"Rheumatology (Oxford)"},{"key":"4764_CR77","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10067-018-4042-1","volume":"37","author":"R Queiro","year":"2018","unstructured":"Queiro R, Lorenzo A, Pardo E et al (2018) Prevalence and type II diabetes-associated factors in psoriatic arthritis. Clin Rheumatol 37:1059\u20131064. https:\/\/doi.org\/10.1007\/s10067-018-4042-1","journal-title":"Clin Rheumatol"},{"key":"4764_CR78","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1136\/annrheumdis-2016-210390","volume":"76","author":"J Shen","year":"2017","unstructured":"Shen J, Wong K-T, Cheng IT et al (2017) Increased prevalence of coronary plaque in patients with psoriatic arthritis without prior diagnosis of coronary artery disease. Ann Rheum Dis 76:1237\u20131244. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210390","journal-title":"Ann Rheum Dis"},{"key":"4764_CR79","doi-asserted-by":"publisher","first-page":"e001364","DOI":"10.1136\/rmdopen-2020-001364","volume":"6","author":"IT Cheng","year":"2020","unstructured":"Cheng IT, Wong KT, Li EK et al (2020) Comparison of carotid artery ultrasound and Framingham risk score for discriminating coronary artery disease in patients with psoriatic arthritis. RMD Open 6:e001364. https:\/\/doi.org\/10.1136\/rmdopen-2020-001364","journal-title":"RMD Open"},{"key":"4764_CR80","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10067-017-3894-0","volume":"37","author":"L Ljung","year":"2018","unstructured":"Ljung L, Sundstr\u00f6m B, Smeds J et al (2018) Patterns of comorbidity and disease characteristics among patients with ankylosing spondylitis\u2014a cross-sectional study. Clin Rheumatol 37:647\u2013653. https:\/\/doi.org\/10.1007\/s10067-017-3894-0","journal-title":"Clin Rheumatol"},{"key":"4764_CR81","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3899\/jrheum.180538","volume":"46","author":"MH Derakhshan","year":"2019","unstructured":"Derakhshan MH, Goodson NJ, Packham JC et al (2019) Increased risk of hypertension associated with spondyloarthritis disease duration: results from the ASAS-COMOSPA study. J Rheumatol 46:701\u2013709. https:\/\/doi.org\/10.3899\/jrheum.180538","journal-title":"J Rheumatol"},{"key":"4764_CR82","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.semarthrit.2014.05.017","volume":"44","author":"IJ Berg","year":"2014","unstructured":"Berg IJ, Semb AG, van der Heijde D et al (2014) Uveitis is associated with hypertension and atherosclerosis in patients with ankylosing spondylitis: a cross-sectional study. Semin Arthritis Rheum 44:309\u2013313. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.05.017","journal-title":"Semin Arthritis Rheum"},{"key":"4764_CR83","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.amjmed.2015.04.032","volume":"128","author":"E Klingberg","year":"2015","unstructured":"Klingberg E, Sve\u00e4lv BG, T\u00e4ng MS et al (2015) Aortic regurgitation is common in ankylosing spondylitis: time for routine echocardiography evaluation? Am J Med 128:1244-1250.e1. https:\/\/doi.org\/10.1016\/j.amjmed.2015.04.032","journal-title":"Am J Med"},{"key":"4764_CR84","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.autrev.2019.05.011","volume":"18","author":"A Mageau","year":"2019","unstructured":"Mageau A, Timsit J-F, Perrozziello A et al (2019) The burden of chronic kidney disease in systemic lupus erythematosus: a nationwide epidemiologic study. Autoimmun Rev 18:733\u2013737. https:\/\/doi.org\/10.1016\/j.autrev.2019.05.011","journal-title":"Autoimmun Rev"},{"key":"4764_CR85","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrrheum.2015.159","volume":"12","author":"A Davidson","year":"2016","unstructured":"Davidson A (2016) What is damaging the kidney in lupus nephritis? Nat Rev Rheumatol 12:143\u2013153. https:\/\/doi.org\/10.1038\/nrrheum.2015.159","journal-title":"Nat Rev Rheumatol"},{"key":"4764_CR86","doi-asserted-by":"publisher","first-page":"102371","DOI":"10.1016\/j.autrev.2019.102371","volume":"18","author":"P Munguia-Realpozo","year":"2019","unstructured":"Munguia-Realpozo P, Mendoza-Pinto C, Sierra Benito C et al (2019) Systemic lupus erythematosus and hypertension. Autoimmun Rev 18:102371. https:\/\/doi.org\/10.1016\/j.autrev.2019.102371","journal-title":"Autoimmun Rev"},{"key":"4764_CR87","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13075-019-1868-0","volume":"21","author":"H-A Chen","year":"2019","unstructured":"Chen H-A, Hsu T-C, Yang S-C et al (2019) Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study. Arthritis Res Ther 21:82. https:\/\/doi.org\/10.1186\/s13075-019-1868-0","journal-title":"Arthritis Res Ther"},{"key":"4764_CR88","doi-asserted-by":"publisher","first-page":"102427","DOI":"10.1016\/j.autrev.2019.102427","volume":"19","author":"T Chazal","year":"2020","unstructured":"Chazal T, Kerneis M, Guedeney P et al (2020) Coronary artery disease in systemic lupus: a case-controlled angiographic study. Autoimmun Rev 19:102427. https:\/\/doi.org\/10.1016\/j.autrev.2019.102427","journal-title":"Autoimmun Rev"},{"key":"4764_CR89","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccm.2019.05.001","volume":"40","author":"A Perelas","year":"2019","unstructured":"Perelas A, Arrossi AV, Highland KB (2019) Pulmonary manifestations of systemic sclerosis and mixed connective tissue disease. Clin Chest Med 40:501\u2013518. https:\/\/doi.org\/10.1016\/j.ccm.2019.05.001","journal-title":"Clin Chest Med"},{"key":"4764_CR90","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/rheumatology\/key151","volume":"58","author":"D Khanna","year":"2019","unstructured":"Khanna D, Tashkin DP, Denton CP et al (2019) Ongoing clinical trials and treatment options for patients with systemic sclerosis-associated interstitial lung disease. Rheumatology (Oxford) 58:567\u2013579. https:\/\/doi.org\/10.1093\/rheumatology\/key151","journal-title":"Rheumatology (Oxford)"},{"key":"4764_CR91","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/art.40862","volume":"71","author":"A Young","year":"2019","unstructured":"Young A, Vummidi D, Visovatti S et al (2019) Prevalence, treatment, and outcomes of coexistent pulmonary hypertension and interstitial lung disease in systemic sclerosis. Arthritis Rheumatol 71:1339\u20131349. https:\/\/doi.org\/10.1002\/art.40862","journal-title":"Arthritis Rheumatol"},{"key":"4764_CR92","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00296-018-4118-x","volume":"38","author":"A Jain","year":"2018","unstructured":"Jain A, Srinivas BH, Emmanuel D et al (2018) Renal involvement in primary Sjogren\u2019s syndrome: a prospective cohort study. Rheumatol Int 38:2251\u20132262. https:\/\/doi.org\/10.1007\/s00296-018-4118-x","journal-title":"Rheumatol Int"},{"key":"4764_CR93","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.autrev.2016.09.017","volume":"16","author":"F Roca","year":"2017","unstructured":"Roca F, Dominique S, Schmidt J et al (2017) Interstitial lung disease in primary Sj\u00f6gren\u2019s syndrome. Autoimmun Rev 16:48\u201354. https:\/\/doi.org\/10.1016\/j.autrev.2016.09.017","journal-title":"Autoimmun Rev"},{"key":"4764_CR94","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.autrev.2017.05.008","volume":"16","author":"MA Alba","year":"2017","unstructured":"Alba MA, Flores-Su\u00e1rez LF, Henderson AG et al (2017) Interstital lung disease in ANCA vasculitis. Autoimmun Rev 16:722\u2013729. https:\/\/doi.org\/10.1016\/j.autrev.2017.05.008","journal-title":"Autoimmun Rev"},{"key":"4764_CR95","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/ndt\/gfw046","volume":"32","author":"S Moiseev","year":"2017","unstructured":"Moiseev S, Novikov P, Jayne D, Mukhin N (2017) End-stage renal disease in ANCA-associated vasculitis. Nephrol Dial Transplant 32:248\u2013253. https:\/\/doi.org\/10.1093\/ndt\/gfw046","journal-title":"Nephrol Dial Transplant"},{"key":"4764_CR96","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s10067-017-3947-4","volume":"37","author":"Y Qi","year":"2018","unstructured":"Qi Y, Yang L, Zhang H et al (2018) The presentation and management of hypertension in a large cohort of Takayasu arteritis. Clin Rheumatol 37:2781\u20132788. https:\/\/doi.org\/10.1007\/s10067-017-3947-4","journal-title":"Clin Rheumatol"},{"key":"4764_CR97","first-page":"115","volume":"33","author":"P Jiang","year":"2015","unstructured":"Jiang P, Li H, Li X (2015) Diabetes mellitus risk factors in rheumatoid arthritis: a systematic review and meta-analysis. Clin Exp Rheumatol 33:115\u2013121","journal-title":"Clin Exp Rheumatol"},{"key":"4764_CR98","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jbspin.2016.09.001","volume":"84","author":"J Nicolau","year":"2017","unstructured":"Nicolau J, Lequerr\u00e9 T, Bacquet H, Vittecoq O (2017) Rheumatoid arthritis, insulin resistance, and diabetes. Joint Bone Spine 84:411\u2013416. https:\/\/doi.org\/10.1016\/j.jbspin.2016.09.001","journal-title":"Joint Bone Spine"},{"key":"4764_CR99","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/acr.22932","volume":"69","author":"Y Liu","year":"2017","unstructured":"Liu Y, Hazlewood GS, Kaplan GG et al (2017) Impact of obesity on remission and disease activity in rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res 69:157\u2013165. https:\/\/doi.org\/10.1002\/acr.22932","journal-title":"Arthritis Care Res"},{"key":"4764_CR100","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00296-016-3487-2","volume":"37","author":"KM Yim","year":"2017","unstructured":"Yim KM, Armstrong AW (2017) Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms. Rheumatol Int 37: 97\u2013105. https:\/\/doi.org\/10.1007\/s00296-016-3487-2","journal-title":"Rheumatol Int"},{"key":"4764_CR101","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrcardio.2014.206","volume":"12","author":"M Prasad","year":"2015","unstructured":"Prasad M, Hermann J, Gabriel SE et al (2015) Cardiorheumatology: cardiac involvement in systemic rheumatic disease.\u00a0Nat Rev Cardiol 12:168\u2013176. https:\/\/doi.org\/10.1038\/nrcardio.2014.206","journal-title":"Nat Rev Cardiol"},{"key":"4764_CR102","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.autrev.2017.12.001","volume":"17","author":"KS Lee","year":"2018","unstructured":"Lee KS,\u00a0Kronbichler A,\u00a0Eisenhut M\u00a0et al (2018) Cardiovascular involvement in systemic rheumatic diseases: an integrated view for the treating physicians. Autoimmun Rev 17:201\u2013214. https:\/\/doi.org\/10.1016\/j.autrev.2017.12.001","journal-title":"Autoimmun Rev"},{"key":"4764_CR103","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10067-020-05275-1","volume":"39","author":"S Ahmed","year":"2020","unstructured":"Ahmed S, Zimba O, Gasparyan AY (2020) Thrombosis in coronavirus disease 2019 (COVID-19) through the prism of Virchow\u2019s triad. Clin Rheumatol 39:2529\u20132543.\u00a0https:\/\/doi.org\/10.1007\/s10067-020-05275-1","journal-title":"Clin Rheumatol"},{"key":"4764_CR104","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00296-016-3636-7","volume":"37","author":"R Giacomelli","year":"2017","unstructured":"Giacomelli R, Liakouli V, Berardicurti O et al (2017) Interstitial lung disease in systemic sclerosis: current and future treatment. Rheumatol Int 37:853\u2013863. https:\/\/doi.org\/10.1007\/s00296-016-3636-7","journal-title":"Rheumatol Int"},{"key":"4764_CR105","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00296-017-3916-x","volume":"38","author":"D S\u00e1nchez-Cano","year":"2018","unstructured":"S\u00e1nchez-Cano D,\u00a0Ortego-Centeno N,\u00a0Callejas JL\u00a0et al (2018) Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group. Rheumatol Int 38:363\u2013374. https:\/\/doi.org\/10.1007\/s00296-017-3916-x","journal-title":"Rheumatol Int"},{"key":"4764_CR106","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/rheumatology\/kex077","volume":"57","author":"S Reiseter","year":"2018","unstructured":"Reiseter S, Gunnarsson R, Mogens Aal\u00f8kken T et al (2018) Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study. Rheumatology (Oxford) 57:255\u2013262. https:\/\/doi.org\/10.1093\/rheumatology\/kex077","journal-title":"Rheumatology (Oxford)"},{"key":"4764_CR107","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1183\/16000617.00002015","volume":"24","author":"J-C Lega","year":"2015","unstructured":"Lega JC, Reynaud Q, Belot A et al (2015) Idiopathic inflammatory myopathies and the lung. Eur Respir Rev 24:216\u2013238. https:\/\/doi.org\/10.1183\/16000617.00002015","journal-title":"Eur Respir Rev"},{"key":"4764_CR108","doi-asserted-by":"publisher","first-page":"e0224772","DOI":"10.1371\/journal.pone.0224772","volume":"14","author":"P Guisado-Vasco","year":"2019","unstructured":"Guisado-Vasco P, Silva M, Duarte-Mill\u00e1n MA et al (2019) Quantitative assessment of interstitial lung disease in Sj\u00f6gren\u2019s syndrome. PLoS ONE 14:e0224772. https:\/\/doi.org\/10.1371\/journal.pone.0224772","journal-title":"PLoS ONE"},{"key":"4764_CR109","doi-asserted-by":"publisher","first-page":"102447","DOI":"10.1016\/j.autrev.2019.102447","volume":"19","author":"G Sambataro","year":"2020","unstructured":"Sambataro G, Ferro F, Orlandi M et al (2020) Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sj\u04e7gren\u2019s syndrome: a systematic review from the Italian Society of Rheumatology. Autoimmun Rev 19:102447. https:\/\/doi.org\/10.1016\/j.autrev.2019.102447","journal-title":"Autoimmun Rev"},{"key":"4764_CR110","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11255-019-02346-4","volume":"52","author":"S Raksasuk","year":"2020","unstructured":"Raksasuk S, Ungprasert P (2020) Patients with rheumatoid arthritis have an increased risk of incident chronic kidney disease: a systematic review and meta-analysis of cohort studies. Int Urol Nephrol 52:147\u2013154. https:\/\/doi.org\/10.1007\/s11255-019-02346-4","journal-title":"Int Urol Nephrol"},{"key":"4764_CR111","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.rdc.2018.06.008","volume":"44","author":"T Kapoor","year":"2018","unstructured":"Kapoor T, Bathon J (2018) Renal manifestations of rheumatoid arthritis. Rheum Dis Clin North Am 44:571\u2013584. https:\/\/doi.org\/10.1016\/j.rdc.2018.06.008","journal-title":"Rheum Dis Clin North Am"},{"key":"4764_CR112","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/tri.12923","volume":"30","author":"D Bertrand","year":"2017","unstructured":"Bertrand D, Dehay J, Ott J et al (2017) Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study. Transpl Int 30:256\u2013265. https:\/\/doi.org\/10.1111\/tri.12923","journal-title":"Transpl Int Off J Eur Soc Organ Transplant"},{"key":"4764_CR113","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1093\/rheumatology\/ket169","volume":"52","author":"F Matcham","year":"2013","unstructured":"Matcham F, Rayner L, Steer S, Hotopf M (2013) The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 52:2136\u20132148. https:\/\/doi.org\/10.1093\/rheumatology\/ket169","journal-title":"Rheumatology (Oxford)"},{"key":"4764_CR114","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S2215-0366(18)30255-4","volume":"6","author":"L Nerurkar","year":"2019","unstructured":"Nerurkar L, Siebert S, McInnes IB, Cavanagh J (2019) Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatry 6:164\u2013173. https:\/\/doi.org\/10.1016\/S2215-0366(18)30255-4","journal-title":"Lancet Psychiatry"},{"key":"4764_CR115","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bbi.2010.10.008","volume":"25","author":"J Blume","year":"2011","unstructured":"Blume J, Douglas SD, Evans DL (2011) Immune suppression and immune activation in depression. Brain Behav Immun 25:221\u2013229. https:\/\/doi.org\/10.1016\/j.bbi.2010.10.008","journal-title":"Brain Behav Immun"},{"key":"4764_CR116","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fnbeh.2018.00141","volume":"12","author":"O Ambr\u00e9e","year":"2018","unstructured":"Ambr\u00e9e O, Ruland C, Scheu S et al (2018) Alterations of the innate immune system in susceptibility and resilience after social defeat stress. Front Behav Neurosci 12:141. https:\/\/doi.org\/10.3389\/fnbeh.2018.00141","journal-title":"Front Behav Neurosci"},{"key":"4764_CR117","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/PSY.0000000000000619","volume":"80","author":"\u00c5 Askim","year":"2018","unstructured":"Askim \u00c5, Gustad LT, Paulsen J et al (2018) Anxiety and depression symptoms in a general population and future risk of bloodstream infection: the HUNT study. Psychosom Med 80:673\u2013679. https:\/\/doi.org\/10.1097\/PSY.0000000000000619","journal-title":"Psychosom Med"},{"key":"4764_CR118","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13075-019-1997-5","volume":"21","author":"C-Y Hsu","year":"2019","unstructured":"Hsu C-Y, Ko C-H, Wang J-L et al (2019) Comparing the burdens of opportunistic infections among patients with systemic rheumatic diseases: a nationally representative cohort study. Arthritis Res Ther 21:211. https:\/\/doi.org\/10.1186\/s13075-019-1997-5","journal-title":"Arthritis Res Ther"},{"key":"4764_CR119","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.rdc.2016.09.005","volume":"43","author":"PA Bryant","year":"2017","unstructured":"Bryant PA, Baddley JW (2017) Opportunistic infections in biological therapy, risk and prevention. Rheum Dis Clin North Am 43:27\u201341. https:\/\/doi.org\/10.1016\/j.rdc.2016.09.005","journal-title":"Rheum Dis Clin North Am"},{"key":"4764_CR120","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/1756-185X.13596","volume":"22","author":"Y Shi","year":"2019","unstructured":"Shi Y, Wu Y, Ren Y et al (2019) Infection risks of rituximab versus non-rituximab treatment for rheumatoid arthritis: a systematic review and meta-analysis. Int J Rheum Dis 22:1361\u20131370. https:\/\/doi.org\/10.1111\/1756-185X.13596","journal-title":"Int J Rheum Dis"},{"key":"4764_CR121","first-page":"317","volume":"36","author":"PL Meroni","year":"2018","unstructured":"Meroni PL, Zavaglia D, Girmenia C (2018) Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs. Clin Exp Rheumatol 36:317\u2013328","journal-title":"Clin Exp Rheumatol"},{"key":"4764_CR122","doi-asserted-by":"publisher","first-page":"e001041","DOI":"10.1136\/rmdopen-2019-001041","volume":"5","author":"V Furer","year":"2019","unstructured":"Furer V,\u00a0Rondaan C,\u00a0Heijstek M\u00a0et al (2019) Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD.\u00a0RMD Open 5:e001041. https:\/\/doi.org\/10.1136\/rmdopen-2019-001041","journal-title":"RMD Open"},{"key":"4764_CR123","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1136\/heartjnl-2020-317393","volume":"106","author":"J Hippisley-Cox","year":"2020","unstructured":"Hippisley-Cox J, Young D, Coupland C et al (2020) Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart 106:1503\u20131511. https:\/\/doi.org\/10.1136\/heartjnl-2020-317393","journal-title":"Heart"},{"key":"4764_CR124","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11883-020-00880-6","volume":"22","author":"R Baral","year":"2020","unstructured":"Baral R, White M, Vassiliou VS (2020) Effect of Renin-Angiotensin-aldosterone system inhibitors in patients with COVID-19: a systematic review and meta-analysis of 28,872 patients. Curr Atheroscler Rep 22:61. https:\/\/doi.org\/10.1007\/s11883-020-00880-6","journal-title":"Curr Atheroscler Rep"},{"key":"4764_CR125","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/art.40892","volume":"71","author":"GD Kitas","year":"2019","unstructured":"Kitas GD, Nightingale P, Armitage J et al (2019) A multicenter, randomized, placebo-controlled trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheumatol Hoboken NJ 71:1437\u20131449. https:\/\/doi.org\/10.1002\/art.40892","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"4764_CR126","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/ncprheum0593","volume":"3","author":"S Toloza","year":"2007","unstructured":"Toloza S, Urowitz MB, Gladman DD (2007) Should all patients with systemic lupus erythematosus receive cardioprotection with statins? Nat Clin Pract Rheumatol 3:536\u2013537. https:\/\/doi.org\/10.1038\/ncprheum0593","journal-title":"Nat Clin Pract Rheumatol"},{"key":"4764_CR127","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ijid.2020.05.115","volume":"96","author":"KCH Lee","year":"2020","unstructured":"Lee KCH, Sewa DW, Phua GC (2020) Potential role of statins in COVID-19. Int J Infect Dis 96:615\u2013617. https:\/\/doi.org\/10.1016\/j.ijid.2020.05.115","journal-title":"Int J Infect Dis"},{"key":"4764_CR128","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cmet.2020.06.015","volume":"32","author":"X-J Zhang","year":"2020","unstructured":"Zhang X-J, Qin J-J, Cheng X et al (2020) In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19. Cell Metab 32:176-187.e4. https:\/\/doi.org\/10.1016\/j.cmet.2020.06.015","journal-title":"Cell Metab"},{"key":"4764_CR129","doi-asserted-by":"publisher","first-page":"3424136","DOI":"10.1155\/2018\/3424136","volume":"2018","author":"A Floris","year":"2018","unstructured":"Floris A, Piga M, Mangoni AA et al (2018) Protective effects of hydroxychloroquine against accelerated atherosclerosis in systemic lupus erythematosus. Mediators Inflamm 2018:3424136. https:\/\/doi.org\/10.1155\/2018\/3424136","journal-title":"Mediators Inflamm"},{"key":"4764_CR130","doi-asserted-by":"publisher","first-page":"e0212614","DOI":"10.1371\/journal.pone.0212614","volume":"14","author":"S Miranda","year":"2019","unstructured":"Miranda S, Billoir P, Damian L et al (2019) Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: role of reduced inflammation and endothelial dysfunction. PLoS ONE 14:e0212614. https:\/\/doi.org\/10.1371\/journal.pone.0212614","journal-title":"PLoS ONE"},{"key":"4764_CR131","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.autrev.2018.01.016","volume":"17","author":"A Casian","year":"2018","unstructured":"Casian A, Sangle SR, D\u2019Cruz DP (2018) New use for an old treatment: hydroxychloroquine as a potential treatment for systemic vasculitis. Autoimmun Rev 17:660\u2013664. https:\/\/doi.org\/10.1016\/j.autrev.2018.01.016","journal-title":"Autoimmun Rev"},{"key":"4764_CR132","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M et al (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med 383:120\u2013128.\u00a0https:\/\/doi.org\/10.1056\/NEJMoa2015432","journal-title":"N Engl J Med"},{"key":"4764_CR133","doi-asserted-by":"publisher","first-page":"102566","DOI":"10.1016\/j.autrev.2020.102566","volume":"19","author":"O Gendelman","year":"2020","unstructured":"Gendelman O, Amital H, Bragazzi NL et al (2020) Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis. Autoimmun Rev 19:102566. https:\/\/doi.org\/10.1016\/j.autrev.2020.102566","journal-title":"Autoimmun Rev"},{"key":"4764_CR134","doi-asserted-by":"publisher","first-page":"e2017539","DOI":"10.1001\/jamanetworkopen.2020.17539","volume":"3","author":"MR Gil","year":"2020","unstructured":"Gil MR, Barouqa M, Szymanski J et al (2020) Assessment of lupus anticoagulant positivity in patients with coronavirus disease 2019 (COVID-19). JAMA Netw Open 3:e2017539\u2013e2017539. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.17539","journal-title":"JAMA Netw Open"},{"key":"4764_CR135","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S2213-8587(20)30183-2","volume":"8","author":"F Mitchell","year":"2020","unstructured":"Mitchell F (2020) Vitamin-D and COVID-19: do deficient risk a poorer outcome? Lancet Diabetes Endocrinol 8:570. https:\/\/doi.org\/10.1016\/S2213-8587(20)30183-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4764_CR136","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2020-138712","author":"V Baktash","year":"2020","unstructured":"Baktash V, Hosack T, Patel N et al (2020) Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J. https:\/\/doi.org\/10.1136\/postgradmedj-2020-138712","journal-title":"Postgrad Med J"},{"key":"4764_CR137","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/oby.22838","volume":"28","author":"SJ Carter","year":"2020","unstructured":"Carter SJ, Baranauskas MN, Fly AD (2020) Considerations for obesity, vitamin D, and physical activity amid the COVID-19 pandemic. Obes Silver Spring Md 28:1176\u20131177. https:\/\/doi.org\/10.1002\/oby.22838","journal-title":"Obes Silver Spring Md"},{"key":"4764_CR138","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4081\/reumatismo.2014.788","volume":"66","author":"M Rossini","year":"2014","unstructured":"Rossini M, Gatti D, Viapiana O et al (2014) Vitamin D and rheumatic diseases. Reumatismo 66:153\u2013170. https:\/\/doi.org\/10.4081\/reumatismo.2014.788","journal-title":"Reumatismo"},{"key":"4764_CR139","doi-asserted-by":"publisher","first-page":"e7024","DOI":"10.1097\/MD.0000000000007024","volume":"96","author":"AS Franco","year":"2017","unstructured":"Franco AS,\u00a0Freitas TQ,\u00a0Bernardo WM,\u00a0Pereira RMR (2017) Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases: a systematic review and meta-analysis. Medicine (Baltimore) 96:e7024. https:\/\/doi.org\/10.1097\/MD.0000000000007024","journal-title":"Medicine (Baltimore)"},{"key":"4764_CR140","doi-asserted-by":"publisher","first-page":"19923","DOI":"10.18632\/aging.104117","volume":"12","author":"J Blanch-Rubi\u00f3","year":"2020","unstructured":"Blanch-Rubi\u00f3 J, Soldevila-Domenech N, T\u00edo L et al (2020) Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions. Aging (Albany NY) 12:19923\u201319937. https:\/\/doi.org\/10.18632\/aging.104117","journal-title":"Aging (Albany NY)"},{"key":"4764_CR141","doi-asserted-by":"publisher","DOI":"10.1080\/02640414.2020.1807089","author":"K Khoramipour","year":"2020","unstructured":"Khoramipour K, Basereh A, Hekmatikar AA, et al (2020) Physical activity and nutrition guidelines to help with the fight against COVID-19. J Sports Sci. https:\/\/doi.org\/10.1080\/02640414.2020.1807089","journal-title":"J Sports Sci"},{"key":"4764_CR142","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/da.22166","volume":"30","author":"H Cramer","year":"2013","unstructured":"Cramer H, Lauche R, Langhorst J, Dobos G (2013) Yoga for depression: a systematic review and meta-analysis. Depress Anxiety 30:1068\u20131083. https:\/\/doi.org\/10.1002\/da.22166","journal-title":"Depress Anxiety"},{"key":"4764_CR143","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00296-020-04639-9","volume":"40","author":"S Shah","year":"2020","unstructured":"Shah S, Danda D, Kavadichanda C et al (2020) Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int 40:1539\u20131554. https:\/\/doi.org\/10.1007\/s00296-020-04639-9","journal-title":"Rheumatol Int"},{"key":"4764_CR144","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","volume":"16","author":"C Galeotti","year":"2020","unstructured":"Galeotti C, Bayry J (2020) Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol 16:413\u2013414. https:\/\/doi.org\/10.1038\/s41584-020-0448-7","journal-title":"Nat Rev Rheumatol"},{"key":"4764_CR145","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41584-020-0451-z","volume":"16","author":"G Schett","year":"2020","unstructured":"Schett G, Manger B, Simon D, Caporali R (2020) COVID-19 revisiting inflammatory pathways of arthritis. Nat Rev Rheumatol 16:465\u2013470. https:\/\/doi.org\/10.1038\/s41584-020-0451-z","journal-title":"Nat Rev Rheumatol"},{"key":"4764_CR146","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26296","author":"EM Saricaoglu","year":"2020","unstructured":"Saricaoglu EM, Hasanoglu I, Guner R (2020) The first reactive arthritis case associated with COVID-19. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.26296","journal-title":"J Med Virol"},{"key":"4764_CR147","doi-asserted-by":"publisher","first-page":"e001350","DOI":"10.1136\/rmdopen-2020-001350","volume":"6","author":"K Ono","year":"2020","unstructured":"Ono K, Kishimoto M, Shimasaki T et al (2020) Reactive arthritis after COVID-19 infection. RMD Open 6:e001350. https:\/\/doi.org\/10.1136\/rmdopen-2020-001350","journal-title":"RMD Open"},{"key":"4764_CR148","doi-asserted-by":"publisher","DOI":"10.1002\/art.41456","author":"RH Haberman","year":"2020","unstructured":"Haberman RH, Castillo R, Chen A et al (2020) COVID-19 in patients with inflammatory arthritis: a prospective study on the effects of comorbidities and DMARDs on clinical outcomes. Arthritis Rheumatol Hoboken NJ. https:\/\/doi.org\/10.1002\/art.41456","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"4764_CR149","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","volume":"5","author":"VO Puntmann","year":"2020","unstructured":"Puntmann VO, Carerj ML, Wieters I et al (2020) Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 5:1265\u20131273. https:\/\/doi.org\/10.1001\/jamacardio.2020.3557","journal-title":"JAMA Cardiol"},{"key":"4764_CR150","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1016\/j.jcmg.2020.05.004","volume":"13","author":"L Huang","year":"2020","unstructured":"Huang L, Zhao P, Tang D et al (2020) Cardiac involvement in patients recovered from COVID-19 identified using magnetic resonance imaging. JACC Cardiovasc Imaging 13:2330\u20132339. https:\/\/doi.org\/10.1016\/j.jcmg.2020.05.004","journal-title":"JACC Cardiovasc Imaging"},{"key":"4764_CR151","doi-asserted-by":"publisher","first-page":"6175964","DOI":"10.1155\/2020\/6175964","volume":"2020","author":"AS Ojo","year":"2020","unstructured":"Ojo AS, Balogun SA, Williams OT, Ojo OS (2020) Pulmonary fibrosis in COVID-19 survivors: predictive factors and risk reduction strategies. Pulm Med 2020:6175964. https:\/\/doi.org\/10.1155\/2020\/6175964","journal-title":"Pulm Med"},{"key":"4764_CR152","doi-asserted-by":"publisher","first-page":"218705","DOI":"10.1136\/annrheumdis-2020-218705","volume":"2020","author":"A Ciurea","year":"2020","unstructured":"Ciurea A, Papagiannoulis E, B\u00fcrki K et al (2020) Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis 2020:annrheumdis-2020-218705. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218705","journal-title":"Ann Rheum Dis"},{"key":"4764_CR153","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/rheumatology\/keaa218","volume":"59","author":"H Jethwa","year":"2020","unstructured":"Jethwa H, Abraham S (2020) Should we be using the Covid-19 outbreak to prompt us to transform our rheumatology service delivery in the technology age? Rheumatology (Oxford) 59:1469\u20131471. https:\/\/doi.org\/10.1093\/rheumatology\/keaa218","journal-title":"Rheumatology (Oxford)"},{"key":"4764_CR154","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.3346\/jkms.2020.35.e176","volume":"35","author":"AY Gasparyan","year":"2020","unstructured":"Gasparyan AY, Misra DP, Yessirkepov M, Zimba O (2020) Perspectives of immune therapy in coronavirus disease 2019. J Korean Med Sci 35:e176. https:\/\/doi.org\/10.3346\/jkms.2020.35.e176","journal-title":"J Korean Med Sci"},{"key":"4764_CR155","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00296-020-04629-x","volume":"40","author":"E Kastritis","year":"2020","unstructured":"Kastritis E, Kitas GD, Vassilopoulos D et al (2020) Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes. Rheumatol Int 40:1353\u20131360. https:\/\/doi.org\/10.1007\/s00296-020-04629-x","journal-title":"Rheumatol Int"},{"key":"4764_CR156","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00296-020-04566-9","volume":"40","author":"V Venerito","year":"2020","unstructured":"Venerito V, Lopalco G, Iannone F (2020) COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence. Rheumatol Int 40:827\u2013828. https:\/\/doi.org\/10.1007\/s00296-020-04566-9","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04764-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-020-04764-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04764-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T18:10:42Z","timestamp":1611598242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-020-04764-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":156,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["4764"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04764-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"6 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no potential conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}